Search for: "Genentech, Inc."
Results 101 - 120
of 469
Sort by Relevance
|
Sort by Date
12 Jul 2017, 9:17 pm
Celltrion, Inc. v Genentech, Inc. [read post]
27 Jun 2017, 9:10 pm
Genentech, Inc., 181 P.3d 142, 156–57 (Cal. 2008). [read post]
26 Jun 2017, 1:58 pm
An insightful article by reported Charles Piller, "Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients"(subscription required), published June 5, 2017 online by STAT, put the spotlight on some serious but little-known side effects associated with this medicine from Genentech, Inc. [read post]
21 Jun 2017, 2:34 pm
Genentech, Inc. v. [read post]
25 May 2017, 8:40 am
We will continue to follow this possible safety issue for Ocrevus, a new multiple sclerosis (MS) from Genentech and Roche. [read post]
16 May 2017, 10:24 am
Genentech, Inc., 549 U.S. 118, 127 (2007) (focusing on declaratory jurisdiction). [read post]
28 Apr 2017, 9:56 am
Genentech Inc.), industrial applicability (HGS v. [read post]
18 Apr 2017, 4:34 pm
See, e.g., Genentech, Inc. v. [read post]
2 Apr 2017, 9:55 pm
Genentech, Inc. [read post]
16 Mar 2017, 8:41 am
Genentech, Inc., 363 F.3d 1247, 1258-59 (Fed. [read post]
31 Jan 2017, 5:48 pm
Genentech, Inc., 76 U. [read post]
19 Jan 2017, 4:50 pm
While refusing to license Phigenix’s patent, Genentech licensed a patent from ImmunoGen, Inc., for use in making Kadcyla. [read post]
10 Jan 2017, 2:42 pm
ImmunoGen, Inc. [read post]
25 Oct 2016, 1:22 am
In 2013, the EMA asked the MHRA to reinspect facilities at Roche in the UK and at its subsidiary, Genentech Inc., in the US. [read post]
8 Sep 2016, 11:29 am
Genentech, Inc., 549 U.S. 118, 127 (2007) In MedImmune, the Court explained the test as “whether the facts alleged, under all the circumstances, show that there is a substantial controversy, between parties having adverse legal interests, of sufficient immediacy and reality to warrant the issuance of a declaratory judgment. [read post]
13 Jun 2016, 8:00 am
Settlement in Suit Alleging Pharmaceutical Companies Misled Doctors and Others About Cancer Drug On June 6, the Department of Justice (“DOJ”) announced that Genentech Inc. and OSI Pharmaceuticals LLC will collectively pay $67 million to settle allegations the companies made misleading statements about the drug Tarceva. [read post]
15 May 2016, 7:04 pm
Comanche County Memorial Hospital said San Francisco-based Genentech shortchanged hospitals by putting less Herceptin in the bottleThe post Genentech Inc., Sued For Cheating Providers appeared first on Legal Reader. [read post]
10 Apr 2016, 1:47 am
However, many cases fall somewhere between these two extremes, with an opposition being only partly successful, and/or the Hearing Officer finding that successful grounds of opposition might nonetheless be overcome by some form of amendment to the patent specification and claims.An example of this last type of outcome is the subject of a recent decision of the Federal Court of Australia in Merck Sharpe & Dohme (Australia) Pty Ltd v Genentech Inc [2016] FCA 324, which… [read post]
22 Mar 2016, 6:12 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
